Serum, saliva, and gingival crevicular fluid osteocalcin: Their relation to periodontal status and bone mineral density in postmenopausal women

Journal of Periodontology

Volumn 76, Issue 4, 2005, Pages 513-519

  Bullon, Pedro ^a,c   Goberna, Berta ^a   Guerrero, Juan M ^b   Segura, Juan J ^a   Perez Cano, Ramon ^b   Martinez Sahuquillo, Angel ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c NONE   (Spain)

Author keywords

Bone resorption prevention and control; Gingival crevicular fluid analysis; Osteocalcin; Osteopenia; Osteoporosis; Periodontitis; Plasma analysis; Saliva analysis

Indexed keywords

OSTEOCALCIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BONE DENSITY; BONE MINERAL; CHI SQUARE TEST; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GINGIVA; HUMAN; KRUSKAL WALLIS TEST; PERIODONTITIS; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; SALIVA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANALYSIS OF VARIANCE; BONE DENSITY; BONE DISEASES, METABOLIC; CHI-SQUARE DISTRIBUTION; DENSITOMETRY, X-RAY; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PERIODONTITIS; POSTMENOPAUSE; SALIVA; SPINE; STATISTICS, NONPARAMETRIC;

EID: 19044383896     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.4.513     Document Type: Article

References (38)

1. Garnero P. Markers of bone turnover for the prediction of fracture risk. Osteoporos Int 2000;11(Suppl. 6):S55-S65.
2. Lee AJ, Walsh TF, Hodges SJ, Rawlinson A. Gingival crevicular fluid osteocalcin in adult periodontitis. J Clin Periododntol 1999;26:252-256.
3. Wactawski-Wende J. Periodontal diseases and osteoporosis: Association and mechanisms. Ann Periodontol 2001; 6:197-208.
4. Hreshchyshn MM, Hopkins A, Zylstra S, Anbar M. Effects of natural menopause, hysterectomy and oophorectomy on lumbar spine and femoral neck bone densities. Obstet Gynecol 1988;72:631-638.
5. Riggs BL, Melton LJ. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 1986;75: 899-901.
6. Roach HI. Why does bone matrix contain non-collagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin and bone sialoprotein in bone mineralisation and resorption. Cell Biol Int 1994;18:617-628.
7. Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev 1989;69:990-1047.
8. Delmas PD. Clinical use of biochemical markers of bone remodeling in osteoporosis. Bone 1992;13(Suppl. 1): S17-S21.
9. Christenson RH. Biochemical markers of bone metabolism: An overview. Clin Biochem 1997;30:573-593.
10. Giannobile WV, Lynch SE, Denmark RG, Paquette DW, Fiorellini JP, Williams RC. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis: A pilot study in beagle dogs. J Clin Periodontol 1995;22:903-910.
11. Giannobile WV, Al-Shammari KF, Sarment DP. Matrix molecules and growth factors as indicators of periodontal disease activity. Periodontology 2000 2003;31:125-134.
12. Curtis MA, Gillett IR, Griffiths GS, et al. Detection of high-risk groups and individuals for periodontal diseases: Laboratory markers from analysis of gingival crevicular fluid. J Clin Periodontol 1989;16:1-11.
13. Page RC. Host response tests for diagnosing periodontal diseases. J Periodontol 1992;63:356-366.
14. Griffiths GS. Formation, collection and significance of gingival crevice fluid. Periodontology 2000 2003;31:32-42.
15. Uitto V-J, Overall CM, McCulloch C. Proteolytic host cell enzymes in ginigival crevice fluid. Periodontology 2000 2002;31:77-104.
16. Golub LM, Lee HM, Greenwald RA, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 1997;46:310-319.
17. Nomura T, Ishii A, Oishi Y, Kohma H, Hara K. Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: The relevance to periodontal diseases. Oral Dis 1998;4:231-240.
18. Kunimatsu K, Mataki S, Tanaka H, et al. A cross-sectional study on osteocalcin levels in gingival crevicular fluid from periodontal patients. J Periodontol 1993;64: 865-869.
19. 2 and alkaline phosphatase in gingival crevicular fluid: Their relations to periodontal status. J Clin Periodontol 1994;21:327-333.
20. Nakashima K, Giannopoulou C, Andersen E, et al. A longitudinal study of various crevicular fluid components as markers of periodontal disease activity. J Clin Periodontol 1996;23:832-838.
21. Wilson AN, Schmid MJ, Marx DB, Reinhardt RA. Bone turnover markers in serum and periodontal microenvironments. J Periodontal Res 2003;38:355-361.
22. O'Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol 1972;43:38.
23. Van der Velden U. Probing force and relationship of the probe tip to the periodontal tissues. J Clin Perlodontol 1979;6:106-114.
24. Machtei EE, Christersson LA, Grossi SG, Dunford R, Zambon JJ, Genco RJ. Clinical criteria for the definition of established periodontitis. J Periodontol 1992;63: 207-215.
25. Nomura T, Ishii A, Shimizu H, et al. Tissue inhibitor of metalloproteinases-1, matrix metalloproteinases-1 and -8, and collagenase activity levels in peri-implant crevicular fluid after implantation. Clin Oral Implants Res 2000;11:430-440.
26. Gonzalez C, Guerrero JM, Elorza FL, Molinero P, Goberna R. Evaluation of maternal serum alpha-fotoprotein assay using dry blood spot samples. J Clin Chem Clin Biochem 1988;26:79-84.
27. Chamoles NA, Blanco MB, Gaggioli C. Hurler-like phenotype: Enzymatic diagnosis in dried blood spots on filter paper. Clin Chem 2001;47:2098-2102.
28. Lee HJ, Auken S, Kulkarni G, et al. Collagenase activity in recurrent periodontics: Relationship to disease progression and doxycycline therapy. J Periodontal Res 1991; 26:479-485.
29. World Health Organization. Assessment of fracture risk and its applications to screening for postmenopausal osteoporosis. WHO Technical Report Series. Geneva: WHO; 1994.
30. Ducy P, Schinke T, Karsenty G. The osteoblast: A sophisticated fibroblast under central surveillance. Science 2000;289:1501-1504.
31. Ivanovski S, Li H, Haase HR, Bartold PM. Expression of bone associated macromolecules by gingival and periodontal ligament fibroblasts. J Periodontal Res 2001;36: 131-141.
32. Ducy P, Desbois C, Boyce B, et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996;382: 448-452.
33. Baumgrass R, Williamson MK, Price PA. Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H, and S. J Bone Miner Res 1997;12: 447-455.
34. Slovik DM, Gundberg CM, Neer RM, Lian JB. Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. J Clin Endocrinol Metab 1984;59:228-230.
35. Garnero P, Hausher E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study. Osteoporos Int 1996;11: 1531-1538.
36. Bauer DC, Sklarin PM, Stone KL, Black DM. Biochemical markers of bone turnover and prediction of hip bone loss in older women: The study of osteoporotic fractures. J Bone Miner Res 1999;14:1404-1410.
37. Looker AC, Bauer DC, Chesnut CH III, et al. Clinical use of biochemical markers of bone remodelling: Current status and future directions. Osteoporos Int 2000;11:467-480.
38. Lian JB, Gundberg CM. Osteocalcin. Biochemical consideration and clinical applications. Clin Orthop 1988; 226:267-291.